Samsung Biologics(207940) Labor and management have held more than 20 rounds of talks over pay raises and personnel system improvements, but still have not narrowed their differences. The union said it would step up external activities, including visits to local governments and the National Assembly.
Samsung Biologics Win-Win Labor Union said on the 16th in a statement, "We held 21 rounds of negotiations through the previous day, including the 16th round on the 16th of last month, but it appears the company has presented no proposal and is only waiting for the outcome of the injunction lawsuit."
The union said, "The company has made no particular proposals not only on agenda items that involve wages and benefits, which entail expense, but also on system improvement plans that do not incur expense, and on some issues it presented plans that were a step back from the existing ones."
It added, "Since May the union has been negotiating on the basis of a revised proposal that lowers its demands, but the talks have shown no progress."
The union said, "Alongside responding to the lawsuit, we met with the Incheon City secretary's office on the 14th, and we plan to strengthen external activities by pursuing a meeting with the Incheon mayor and meetings with offices of lawmakers on the Environment and Labor Committee of the National Assembly."
Regarding the recent dismissal of its unfair labor practice relief application, the union also said it plans to file for a reexamination with the Central Labor Relations Commission.